People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy that draws lead and other toxic metals linked to increased risk of heart disease and stroke out of the body, according to a study presented at the American College of Cardiology's Annual Scientific Session.
Edetate disodium-based chelation ineffective for heart attack patients with diabetes
- Thread starter Educator
- Start date